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AbstractsL2 and L3, with poor coverage of T12. An in vivo
study should be performed to evaluate the analgesic
efﬁcacy of this technique in mid to caudal abdominal
surgeries.
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Introduction: The study objective was to evaluate
sedative and physiologic effects of midazolam associ-
ated with a combination of methadone and alfax-
alone for IM premedication in dogs.
Methods: Sixteen healthy dogs of various breeds,
weighing 5e12 kg, classiﬁed ASA status I-II,
randomly received a combination of 0.5 mg kg1 of
methadone and 1 mg kg1 of alfaxalone with (MMA)
or without (MA) 0.5 mg kg1 of midazolam by IM
injection. Quality of sedation was assessed at 10, 15,
20 and 25 minutes post-injection, by an observer
blinded to treatment. Cardiovascular, respiratory
variables and additional intravenous alfaxalone
required for endotracheal intubation were recorded.
Data were analyzed with mixed-effect linear model on
rank or Mann-Whitney rank-sum test (p 0.05).
Results: There was no signiﬁcant difference over
time in heart rate, respiratory rate, systolic blood
pressure, SpO2 and temperature between MA and
MMA premedication. Sedation increased over time (p
< 0.01), however dogs premedicated with MMA
appeared signiﬁcantly less sedated than dogs pre-
medicated with MA at 15 (p¼ 0.02), 20 (p¼ 0.02)
and 25 minutes (p¼ 0.01) post-injection. This was
substantiated by the fact that dogs premedicated with
MMA were almost four times more likely to show
delirium than those premedicated with MA (OR 3.95,
CI 0.69-7.21, p¼ 0.02). The amount of alfaxalone
needed for intubation did not differ between treat-
ments (p¼ 0.92).
Conclusion: Results suggest that adding midazolam
to an IM combination of methadone and alfaxalone1262.e9does not improve sedation scores or amount of agent
needed for intubation in healthy dogs.
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Introduction: This study aimed to determine the
pharmacokinetics of bupivacaine in combination
with dexmedetomidine or epinephrine after intra-
peritoneal administration in cats.
Methods: Sixteen healthy adult cats (3.3 ± 0.5 kg)
were included in a prospective, randomized, masked
clinical trial after owners’ consent. Anesthetic
protocol included buprenorphineepropofole
isoﬂurane. Meloxicam (0.2 mg kg1) was adminis-
tered subcutaneously before surgery. A catheter was
placed in the jugular vein for blood sampling. A ventral
midline incision was made and equal volumes of
bupivacaine 0.25% (2mg kg1) with epinephrine (BE;
2 mg kg1) or dexmedetomidine (BD; 1 mg kg1) were
injected into the peritoneal space, over the right and
left ovarian pedicles and caudal aspect of the uterus,
before ovariohysterectomy (n¼ 8/group). Blood sam-
ples were collected for up to 8 hours after bupivacaine
administration. Plasma concentrations and pharma-
cokinetics of bupivacainewere determined using liquid
chromatography tandemmass spectrometry and non-
compartmental model, respectively.
Results: Maximum bupivacaine plasma concentra-
tions (Cmax) for BE and BD were 1155 ±
168 ng mL1 and 1678 ± 364 ng mL1 (p¼ 0.29) at
67 ± 13 minutes (Tmax) and 123 ± 59 minutes
(p¼ 0.17), respectively. The elimination half-life and
the clearance (CL/F) were 8.9 ± 8.6 hours and 10.5
± 10.3 hours, and 0.168 ± 0.069 L hour kg1 and
0.132 ± 0.129 L hour kg1 for BE and BD, respec-
tively. Pharmacokinetic parameters were not
different between treatments (p > 0.05).
Conclusion: Intraperitoneal bupivacaine with
epinephrine or dexmedetomidine produced concen-
trations below toxic levels.
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